1-4 of 4
Maria Corinna Palanca-Wessels, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results Of a Phase I Study Of The Anti-CD79b Antibody-Drug Conjugate DCDS4501A In Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)

Maria Corinna Palanca-Wessels, M.D., Ph.D., Gilles Andre Salles, MD, PhD, Myron S. Czuczman, MD, Sarit E. Assouline, MD, Ian W. Flinn, MD, PhD, Laurie H. Sehn, MD, Manish Patel, MD, Randeep Sangha, Herve Tilly, MD, Ranjana Advani, MD, Olivier Casasnovas, MD, Oliver W. Press, MD, PhD, Sreeni Yalamanchili, BSPharm, Robert Kahn, Dan Lu, Akiko Chai, MS, Yu-Waye Chu, Franck Morschhauser
Journal: Blood
Blood (2013) 122 (21): 4400.
https://doi.org/10.1182/blood.V122.21.4400.4400
Published: 2013
Journal Articles

Impact Of Pre-Transplant Rituximab Sensitivity In Relapsed Follicular Lymphoma On Outcome After Autologous Transplant

Colin Phipps, MD, Ajay K. Gopal, MD, Barry E. Storer, PhD, Ryan D. Cassaday, MD, Oliver W. Press, MD, PhD, Brian G. Till, MD, John M. Pagel, MD, PhD, Mary Phillip, Maria Corinna Palanca-Wessels, M.D., Ph.D., William I. Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Edward N. Libby, III, MD
Journal: Blood
Blood (2013) 122 (21): 3365.
https://doi.org/10.1182/blood.V122.21.3365.3365
Published: 2013
Journal Articles

A Phase I Study of the Anti-CD79b Antibody-Drug Conjugate (ADC) DCDS4501A Targeting CD79b in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Maria Corinna Palanca-Wessels, M.D., Ph.D., Ian W. Flinn, MD, PhD, Laurie H. Sehn, MD, MPH, Manish Patel, MD, Randeep Sangha, MD, Myron S. Czuczman, MD, Gilles Andre Salles, MD, PhD, Franck Morschhauser, MD, Ranjana Advani, MD, Oliver W. Press, MD, PhD, William Ho, MD, PhD, Robert Kahn, Dan Lu, Zheng Su, Yu-Waye Chu, Sarit E. Assouline, MD
Journal: Blood
Blood (2012) 120 (21): 56.
https://doi.org/10.1182/blood.V120.21.56.56
Published: 2012
Journal Articles

Full Dose Bendamustine (Treanda ®) Can Be Safely Combined with Rituximab, Etoposide and Carboplatin (TREC): Results of a Phase I Trial in Patients with Relapsed or Refractory Lymphoma

Lihua Elizabeth Budde, MD, PhD, Shustov R Andrei, M.D., Gooley Ted, Ph.D., Tara L Chen, PharmD, BCOP, Edward N. Libby, III, MD, Maria Corinna Palanca-Wessels, M.D., Ph.D., Mary Philip, MD, PhD, Daniel B. Martin, M.D., Ryan D. Cassaday, MD, Kiarash Kojouri, MD, MPH, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2012) 120 (21): 3650.
https://doi.org/10.1182/blood.V120.21.3650.3650
Published: 2012